← Back to all trials
Completed
NCT02262117
Evaluate the Interest of the Pre-conceptional Endometrial Immune Profiling to Increase Birth Rates
Conditions: Reproductive Medicine
Sex: Female
Ages: 18 Years – 38 Years
Healthy volunteers: No
Phase: NA
Enrollment: 493
Sponsor: Assistance Publique - Hôpitaux de Paris
Location: Hôpital Saint-Louis - Laboratoire MatriceLAb Innove Paris
Summary
A prospective, randomized, controlled, open two-arm study to evaluate the interest of the pre-conceptional endometrial immune profiling to increase birth rates.
Eligibility Criteria
Inclusion Criteria:
* Infertile patients will be included at the beginning of their medical care in reproduction once the indication to perform either an IVF with or without ICSI has been established. The indication for IVF will be: tubal infertility, endometriosis, ovarian dysovulation with failure of intra-uterine insemination, idiopathic infertility The indication for ICSI will be: male infertility (oligo-astheno-teratospermia), previous failure of oocytes fertilization in IVF
* Patients should be younger than 38 years old (Age \< 38)
* with a normal ovarian reserve (AMH\>1.5ng/ml, FSH\
Source: ClinicalTrials.gov (NCT02262117). StuddyBuddy aggregates publicly available trial information.
